EJHaem · 2025
B/T Mixed Phenotype Acute Leukaemia Harbouring NUP98::BPTF Fusion.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nguyen Van Tuong, Han Lina, Xu Jing, Cantu Miguel, Fuda Franklin, John Samuel, Slone Tamra, Chen Weina
Аннотация
BACKGROUND: NUP98::BPTF rearranged (r) leukaemia is rare with only five reported cases, including acute myeloid leukemia and T-lymphoblastic leukemia (T-ALL).
RESULTS: Herein, we report a case of NUP98::BPTF-r mixed phenotype acute leukemia (MPAL), B/T with T-lineage-predominance in a 15-year-old female. Cytogenetic and molecular studies revealed a t(11;17)(p15;q23)/NUP98::BPTF fusion and cooperative gene alterations characteristic of T-ALL (NOTCH1, FBXW7, and PHF6). Our patient had a primary induction failure with T-ALL-directed chemotherapy and achieved complete remission following consolidation.
CONCLUSION: This is the first case study characterizing the clinicopathological and genomic features of B/T MPAL harboring NUP98::BPTF fusion and providing insights into molecular pathogenesis.
TRIAL REGISTRATION: The authors have confirmed clinical trial registration is not needed for this submission.
RESULTS: Herein, we report a case of NUP98::BPTF-r mixed phenotype acute leukemia (MPAL), B/T with T-lineage-predominance in a 15-year-old female. Cytogenetic and molecular studies revealed a t(11;17)(p15;q23)/NUP98::BPTF fusion and cooperative gene alterations characteristic of T-ALL (NOTCH1, FBXW7, and PHF6). Our patient had a primary induction failure with T-ALL-directed chemotherapy and achieved complete remission following consolidation.
CONCLUSION: This is the first case study characterizing the clinicopathological and genomic features of B/T MPAL harboring NUP98::BPTF fusion and providing insights into molecular pathogenesis.
TRIAL REGISTRATION: The authors have confirmed clinical trial registration is not needed for this submission.